Editor reviews are provided by professional editors who evaluate a blog based on the following criteria: Frequency of Updates, Relevance of Content, Site Design, and Writing Style.
User rating is calculated as an average of the user ratings. If this rating differs significantly from our editor's rating our editors may re-evaluate this blog.
Click here to follow me on twitter / mikehavrilla and check out the BioMedReports.com FDA Calendar service , Healthcare Stock Indexes , and my kaChing.com virtual investing profile .
$PIP $EBS / Pharmathene and Emergent...
The popular carry trade this year has been shorting the US Dollar and buying gold, oil and US equities. You might say that it is not the commodities appreciating, but the dollar’s depreciating that has lead to the high prices of gold, oil and...
Is it possiable that one deadly drug could take down an entire company?
This movie could be the start and the end!
house of numbers
http://www.youtube.com/watch?v=X_N4zgjF0K0
AZT is a cytotoxic ...
Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space such as Cell Genesys, Favrille, and Genitope; recent advancements and study results are encouraging while...
The BioMedReports.com research download section has been updated to include PDFs for two recent research reports written by Griffin Securities for Clinical Data (NASDAQ: CLDA) and Lpath, Inc. (OTC: LPTN.OB). Lpath received a buy rating...
